Finteca Holdings

Finteca Holdings combines leading Russian and Israeli companies, providing financial and technological services for business.

Holding Company Active Moscow, Russia Est. 2015
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—

About

Finteca Holdings Ltd, incorporated in 2015, is a holding company that integrates Russian and Israeli companies offering financial and technological services. The company focuses on building effective business models through self-developed IT technologies and project synergy. In 2019, Finteca Holdings Ltd rebranded and began operating under the Redstone Capital Investment company brand. The holding also manages startups with high intellectual and technological potential in Russia, the CIS, and Israel, particularly in FinTech and PropTech, to support small and medium-sized businesses. Finteca's business incubator provides infrastructure to startups, including hypothesis testing, MVP development, legal and financial support, and other back-office functions.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Finteca Holdings' most notable exit?
Finteca Holdings exited Chemomab Therapeutics in March 2021 through a reverse merger with Anchiano Therapeutics, which then listed on NASDAQ.
Which sector does Finteca Holdings primarily focus on for its investments and exits?
Finteca Holdings shows a concentration in the Health Tech & Life Sciences sector, with both its portfolio companies and exits falling within this area.
Can you name a key company in Finteca Holdings' portfolio?
A key company in Finteca Holdings' portfolio is Chemomab Therapeutics, which focuses on innovative treatments for fibro-inflammatory-related diseases.
When did Finteca Holdings make its most recent investment?
Finteca Holdings made an investment in December 2019.
What type of funding rounds has Finteca Holdings participated in?
Finteca Holdings has participated in C Round funding stages.
What is the total amount raised by Chemomab Therapeutics, a company in Finteca Holdings' portfolio?
Chemomab Therapeutics has raised $90.5M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Legal nameFinteca Holdings Ltd
Founded2015